October 6, 2022
U.S. News & World Report highlighted recent research from the University of Cincinnati that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
October 6, 2022
Researchers at the University of Cincinnati are leading the CAPSTONE study that will learn more about how inflammation affects patient recovery after intracerebral hemorrhage strokes.
October 5, 2022
The University of Cincinnati's Rifat Wahab, DO, joined WPFW's What's at Stake radio show and podcast to discuss Breast Cancer Awareness Month and racial disparities in breast cancer.
October 4, 2022
University of Cincinnati researchers led by Alberto Espay and Andrea Sturchio published new research that supports the hypothesis that Alzheimer’s disease is caused by a decline in levels of a protein called amyloid-beta.
September 29, 2022
Laser Focus World's Photonics Hot List highlighted the recent work of the University of Cincinnati's Jiajie Diao, PhD, who published research demonstrating a technique that uses light to help naturally balance mitochondria within cells.
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
September 27, 2022
UC's Ann Brown, MD, and breast cancer survivor Michele Young talked with WLWT about House Bill 371, a new law that requires insurance companies to cover additional screenings for individuals who are at high risk for breast cancer or have dense breast tissue, going into effect.
Event: September 29, 2022 3:00 PM
The Register previewed the upcoming Reduce Your Risk Health Fair in Crosby Township and featured comments from UC's Susan Pinney, PhD, about the importance of screening for those who lived near or worked at the Fernald Feed Materials Production Center.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.
September 21, 2022
Medical News Today highlighted recent research led by the University of Cincinnati's Pier Paolo Scaglioni, MD, that found targeting components of lipid metabolism and synthesis could lead to an effective lung cancer treatment.